首页> 美国政府科技报告 >Monoclonal Antibody to an Endogenous Neuropeptide with Putative Morphine-Modulating Activity
【24h】

Monoclonal Antibody to an Endogenous Neuropeptide with Putative Morphine-Modulating Activity

机译:具有推定的吗啡调节活性的内源性神经肽的单克隆抗体

获取原文

摘要

Monoclonal antibodies against phe-leu-phe-gln-pro-gln-arg-phe-NH2 (F-8-F-NH2), a FMRF-NH2-like peptide of bovine brain, have been produced and characterized. The antibodies showed varying degrees of cross-reactivity with peptides having arg-phe-NH2 at their C-termini but no cross-reactivity with met(5)-enkephalin-arg(6)-phe(7), NPY and PYY. The result suggests that these antibodies are directed to the C-terminal dipeptide, arg-phe-NH2, and the conformation of the peptide also contributes to the immunoreactive potency. The result also indicates the monoclonal antibodies are capable of differentiating-RH-NH2, the C-terminal dipeptide amide of FMRF-NH2-like peptides, from RY-NH2, the C-terminal dipeptide amide of NPY. An extract from bovine spinal cord was analyzed by HPLC coupled with RIA using the monoclonal antibodies. The major immunoreactivity was identified as F-8F-NH2 although there were some very small amounts of unidentified immunoreactive species. The specificity of these monoclonal antibodies is thus further confirmed and will be useful in differentiating the distribution of F-8-F-NH2 or mammalian FMRF-NH2-like peptides from that of NPY by immunohistochemical studies. (KT/AW)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号